IBIO vs LLY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 01, 2026

IBIO

63.3
AI Score
VS
IBIO Wins

LLY

34.0
AI Score

Investment Advisor Scores

IBIO

63score
Recommendation
HOLD

LLY

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBIO LLY Winner
Forward P/E 0 26.9542 Tie
PEG Ratio 0 1.2343 Tie
Revenue Growth -100.0% 47.7% LLY
Earnings Growth 0.0% 26.2% LLY
Tradestie Score 63.3/100 34.0/100 IBIO
Profit Margin 0.0% 33.5% LLY
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -30.7% · 3M: -45.9% LLY 1M: +23.3% · 3M: +26.4%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.7%), weak momentum, RSI 35

RSI (14): 35.3 · Price: $0.77

LLY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 78

RSI (14): 77.8 · Price: $1417.54

Fundamentals Snapshot

Metric IBIO LLY
Market Cap — —
Forward P/E -2.5 29.9
Trailing P/E — 43.3
Revenue (TTM) — —
Revenue Growth -1.0% 0.5%
Gross Margin 1.0% 0.8%
Operating Margin -301.4% 0.5%
EPS -0.32 31.76
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.